Corrigendum: The efficacy and safety analysis of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma

Detalles Bibliográficos
Autores principales: Zeng, Zhimin, Qian, Xiaoying, Liu, Fanrong, Wang, Yong, Yuan, Yong, Fang, Chen, Zhang, Xinwei, Yuan, Shangkun, Chen, Renfang, Yu, Biao, Wang, Tong, Yin, Yan, Li, Yong, Liu, Anwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512075/
https://www.ncbi.nlm.nih.gov/pubmed/37744366
http://dx.doi.org/10.3389/fimmu.2023.1269596
Descripción
Sumario:

Ejemplares similares